Q4 2018 Holdings
Filed 2019-01-18 | 46 holdings | $179.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC(ADAPY) | ADR | 00653A107 | $91.0M | 15,832,611 | 50.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $32.8M | 4,808,483 | 18.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $27.5M | 15,335,047 | 15.3% |
| Bloom Energy Corp(BE) | COM CL A | 093712107 | $13.3M | 1,333,333 | 7.4% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $12.2M | 1,562,500 | 6.8% |
| Tesaro Inc | COM | 881569107 | $773.7K | 10,420,555 | 0.4% |
| Elastic NV(ESTC) | ORD SHS | N14506104 | $454.1K | 6,353,498 | 0.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $132.0K | 4,912,306 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $118.6K | 2,268,188 | 0.1% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $111.7K | 6,138,797 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $86.1K | 9,089,041 | 0.0% |
| Senseonics Holdings Inc(SENS1GBP) | COM | 81727U105 | $80.0K | 30,888,266 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $59.7K | 2,090,678 | 0.0% |
| Obseva SA | COM | H5861P103 | $58.1K | 4,586,563 | 0.0% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $53.8K | 2,486,062 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $42.4K | 6,877,518 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $33.4K | 20,896,038 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $33.2K | 8,144,267 | 0.0% |
| Clementia Pharmaceuticals Inc | COM | 185575107 | $31.8K | 2,707,734 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $29.6K | 4,229,410 | 0.0% |
| Marker Therapeutics Inc | COM | 57055L107 | $27.8K | 5,000,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $25.2K | 3,506,649 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $18.6K | 4,141,308 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $18.0K | 5,556,778 | 0.0% |
| Affimed NV | COM | N01045108 | $16.0K | 5,138,888 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $15.8K | 2,382,286 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $15.1K | 5,720,572 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $14.1K | 3,315,149 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $14.0K | 1,766,779 | 0.0% |
| Dasan Zhone Solutions Inc(DZSIEUR) | COM NEW | 23305L206 | $13.3K | 956,255 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $11.0K | 1,219,674 | 0.0% |
| Nightstar Therapeutics PLC | ADR | 65413A101 | $8.2K | 714,285 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $7.5K | 3,243,150 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $7.2K | 25,000,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $7.0K | 2,520,316 | 0.0% |
| Achaogen Inc | COM | 004449104 | $6.4K | 5,215,128 | 0.0% |
| Arsanis Inc | COM | 042873109 | $4.6K | 2,000,000 | 0.0% |
| Erytech Pharma SA | ADR | 29604W108 | $4.2K | 625,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $2.7K | 3,750,000 | 0.0% |
| Tracon Pharmaceuticals Inc | COM | 89237H100 | $2.2K | 3,467,181 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $2.1K | 1,250,000 | 0.0% |
| Endologix Inc | COM | 29266S106 | $1.8K | 2,490,204 | 0.0% |
| Trevena Inc | COM | 89532E109 | $1.6K | 3,811,691 | 0.0% |
| Regulus Therapeutics Inc | COM NEW | 75915K200 | $852 | 915,751 | 0.0% |
| Akari Therapeutics PLC | ADR | 00972G108 | $710 | 452,167 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $539 | 1,298,274 | 0.0% |